FGD5 and breast cancer: FGD5-AS1 is significantly overexpressed in breast cancer tissues and cells and could promote the proliferation, glycolysis, migration, and invasion of BC cells by binding with miR-195-5p and removing the inhibitory effect on NUAK2 expression; moreover, silencing FGD5-AS1 leads to the opposite phenotype [45].